Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Jun 23 · above the Ichimoku cloud · RSI 53 · MACD below its signal · 1% below its 52-week high
None of the 29 investors followed here reported a position in AMS.L in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a AMS.L trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Societe Generale Asset Management (France) | Bought at price 3.74 per share. | 45.5K | $170.08K |
| Oct 6, 2026 | Societe Generale Asset Management (France) | Sold at price 3.79 per share. | 187.7K | $711.73K |
| Oct 6, 2026 | Octopus Investments Ltd | Sold at price 3.72 per share. | 9.6K | $35.69K |
| Oct 6, 2026 | Jefferies International, Ltd. | Bought at price 3.72 per share. | 156.6K | $583.47K |
| Oct 6, 2026 | Jefferies International, Ltd. | Sold at price 3.74 per share. | 156.6K | $585.51K |
| Oct 6, 2026 | Samson Rock Capital Llp | Bought at price 3.72 per share. | 51K | $189.93K |
| Oct 6, 2026 | Hargreave Hale Ltd | Sold at price 3.72 per share. | 7.6K | $28.37K |
| Oct 6, 2026 | Dimensional Fund Advisors, L.P. | Sold at price 3.72 per share. | 336.6K | $1.25M |
| Oct 6, 2026 | Glazer Capital Llc | Sold at price 3.74 per share. | 38.8K | $144.88K |
| Oct 6, 2026 | Barclays, Plc. | Increase at price 3.72 per share. | 13.8K | $51.34K |
| Oct 5, 2026 | Alliancebernstein, L.P. | Bought at price 3.74 per share. | 326.5K | $1.22M |
| Oct 5, 2026 | Barclays, Plc. | Increase at price 3.74 per share. | 6.7K | $25.01K |
| Oct 5, 2026 | Dimensional Fund Advisors, L.P. | Decrease at price 3.74 per share. | 29.5K | $110.53K |
| Oct 5, 2026 | Hargreave Hale Ltd | Sold at price 3.74 per share. | 4.5K | $16.69K |
| Oct 5, 2026 | Samson Rock Capital Llp | Bought at price 3.74 per share. | 60.7K | $227.02K |
| Oct 5, 2026 | Octopus Investments Ltd | Sold at price 3.74 per share. | 21.6K | $80.84K |
| Oct 5, 2026 | Societe Generale Asset Management (France) | Sold at price 3.74 per share. | 85.1K | $318.46K |
| Oct 5, 2026 | Jefferies International, Ltd. | Bought at price 3.74 per share. | 6.3K | $23.52K |
| Oct 5, 2026 | Jefferies International, Ltd. | Sold at price 3.74 per share. | 6.3K | $23.52K |
| Oct 4, 2026 | Jefferies International, Ltd. | Bought at price 3.73 per share. | 40.6K | $151.27K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.1 | -0.5 | -10.5 | 26.6 | -9.9 | 27.9 | 0.0 | 0.7 | 0.2 | 0.0 | +29.6% | ||
| 2025 | 5.8 | 1.4 | 9.4 | -16.8 | 2.4 | 9.8 | -6.9 | 0.2 | 10.9 | -4.2 | 1.6 | -0.2 | +10.3% |
| 2024 | 1.0 | 0.2 | -6.7 | -3.4 | 14.6 | -1.4 | 15.0 | 1.6 | -13.2 | 4.4 | -6.0 | -7.2 | −4.8% |
| 2023 | -1.9 | -1.6 | -11.0 | 10.1 | -8.6 | 0.9 | 10.0 | 2.6 | -21.2 | -3.6 | 4.2 | 2.7 | −19.9% |
| 2022 | -12.7 | -2.0 | 2.9 | -5.7 | 7.3 | -2.0 | -5.1 | 7.5 | -18.9 | 11.9 | 0.2 | -5.3 | −23.4% |
| 2021 | -6.4 | 3.3 | -0.6 | 21.4 | -3.4 | 3.6 | -1.1 | -5.3 | 16.0 | 5.3 | -1.2 | 5.3 | +39.1% |
| 2020 | -4.7 | -9.9 | -1.2 | -2.8 | 2.0 | -4.4 | -19.3 | 25.3 | -10.4 | -2.6 | 16.9 | -1.0 | −17.9% |
| 2019 | 10.7 | 0.2 | 3.8 | 4.3 | 4.1 | -12.7 | -2.7 | 7.5 | -21.5 | -1.0 | 7.0 | 13.4 | +7.6% |
| 2018 | 2.3 | 0.0 | -2.6 | -0.3 | 3.5 | 0.3 | 10.1 | -5.7 | -2.8 | -13.2 | 1.9 | -6.0 | −13.5% |
| 2017 | -9.8 | 6.8 | 13.3 | 9.1 | 8.1 | 1.6 | 2.7 | 6.7 | -8.8 | 19.6 | -9.2 | 1.0 | +43.3% |
| 2016 | -5.7 | 1.0 | 5.1 | 0.6 | 9.2 | -2.1 | 10.8 | 2.8 | 2.7 | -6.7 | 5.3 | -1.0 | +22.3% |
| 2015 | 5.2 | 7.4 | -4.6 | 5.0 | 5.8 | -4.7 | 5.6 | -0.7 | 2.3 | 6.8 | 4.3 | 6.0 | +44.7% |
| 2014 | 12.7 | -9.0 | 13.1 | -1.0 | -6.6 | -5.0 | 0.5 | 14.0 | -3.4 | -3.3 | 1.1 | 5.0 | +15.7% |
| 2013 | 0.8 | 4.7 | 11.1 | 6.0 | -5.3 | -0.3 | 2.3 | 13.4 | 5.2 | 6.8 | 6.4 | 4.1 | +69.1% |
| 2012 | -6.5 | 7.6 | -16.8 | -3.9 | 6.1 | -17.2 | 5.4 | -0.4 | 15.8 | -7.0 | -8.2 | -5.2 | −30.4% |
| 2011 | -3.1 | 5.5 | 28.6 | -12.5 | -5.1 | -6.6 | 0.7 | 2.7 | 12.3 | -1.2 | -10.5 | 20.3 | +26.0% |
| 2010 | 6.2 | 11.7 | -0.7 | 7.9 | 0.0 | 7.9 | 12.4 | 4.5 | 25.5 | 7.3 | -0.7 | 5.0 | +126.4% |
| 2009 | -7.5 | 8.1 | 7.5 | -10.4 | -8.5 | -18.6 | 5.2 | 8.9 | 5.5 | -5.2 | -1.8 | 19.4 | −3.7% |
| 2008 | -7.0 | 24.7 | 6.9 | 9.7 | -5.9 | 3.9 | -3.8 | -6.3 | 11.7 | -10.4 | 6.7 | 4.7 | +34.0% |
| 2007 | 3.6 | 0.0 | 9.6 | 26.4 | 2.5 | 0.0 | 24.7 | -8.9 | 17.4 | -9.3 | 4.1 | -2.0 | +81.8% |
Buy / hold / sell counts
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally. It offers surgical products, such as tissue adhesives, sutures and clips, haemostats, biosurgical, internal fixation devices, infection control, and internal sealants. The company also provides collagens, bone substitutes, resorbable fixation systems, vascular temporary occlusion, dressings, silicone wound contact layers, surgical supplies, debridement, hydrogels, and laparoscopic instruments. It sells its products under the LIQUIFIX, Peters Surgical, Ifabond, INTEGUSEAL, LiquiBand, RESORBA, LiquiBandFix8, Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
No recent headlines.